Verastem Inc (VSTM)
2.87
+0.10
(+3.61%)
USD |
NASDAQ |
Oct 04, 16:00
2.86
-0.01
(-0.35%)
After-Hours: 20:00
Verastem Shareholders Equity (Annual): 57.37M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 57.37M |
| December 31, 2022 | 47.39M |
| December 31, 2021 | 87.56M |
| December 31, 2020 | 115.27M |
| December 31, 2019 | 7.174M |
| December 31, 2018 | 124.30M |
| December 31, 2017 | 57.68M |
| Date | Value |
|---|---|
| December 31, 2016 | 72.30M |
| December 31, 2015 | 102.47M |
| December 31, 2014 | 88.77M |
| December 31, 2013 | 117.45M |
| December 31, 2012 | 90.47M |
| December 31, 2011 | 55.38M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
7.174M
Minimum
2019
115.27M
Maximum
2020
62.95M
Average
57.37M
Median
2023
Shareholders Equity (Annual) Benchmarks
| Sage Therapeutics Inc | 799.53M |
| SeaStar Medical Holding Corp | -13.87M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |